PATENT CLAIM ANALYSIS

Application Number: 16038735
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["514", "176000"]

Abstract:
Described herein are new anti-cancer compounds and methods of using such compounds, acting through a new mechanism of action by simultaneous inhibition of leukemia inhibitory factor (LIF) and MDM2.

Claim (Index 41):
A method of treating cancer in a subject comprising administering to a subject a medicament comprising an effective amount of a cytotoxic small molecule compound having the structure (III): where:\n R 2  and R 3  is F; \n R 4  is H, alkyl, \u2014CH 2 \u2014OH, \u2014CO 2 R 6 , \u2014CON(R 6 ) 2 ; \n R 5  is a heterocycle; and \n R 6  is H, alkyl, or cycloalkyl.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 95.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15077099', '12995669', '15923668', '14678905', '15419642']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.703396730019908
- 35 USC 102 Novelty (BERT): 0.5573623834935738
- Combined Prediction Score: 0.6887932953672746
- Mean Citation Score: 263.773224
- Max Citation Score: 442.86853
- Similarity Product: 276.0714534488297

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test